Vimarsana
Biggest News Aggregation in the World

Page 4 - Murray Kessler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Murray Kessler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Murray Kessler Today - Breaking & Trending Today

FDA advisers vote unanimously in support of over-the-counter birth-control pill - Vimarsana News

FDA advisers vote unanimously in support of over-the-counter birth-control pill

Two FDA advisory panels agreed that people would use Opill safely and effectively.

FDA advisers vote unanimously in support of over-the-counter birth-control pill - Vimarsana News

FDA advisers vote unanimously in support of over-the-counter birth-control pill

Advisers for the US Food and Drug Administration voted unanimously on Wednesday in support of making the birth-control pill Opill available over-the-counter, saying the benefits outweigh the risks.

Source: wxow.com
Baby formula makers hike prices, blaming new U.S. guidelines - Vimarsana News

Baby formula makers hike prices, blaming new U.S. guidelines

Prices of baby food and formula hit an all-time high last month as suppliers rushed to adjust to new government guidance to avoid another shortage.

Perrigo: Murray Kessler To Retire; Delivers Double-digit Top Line Growth In Q1, Reaffirms Outlook - Vimarsana News

Perrigo: Murray Kessler To Retire; Delivers Double-digit Top Line Growth In Q1, Reaffirms Outlook

Perrigo Company plc (PRGO) announced that Murray Kessler has notified the company of his intent to retire as President and Chief Executive Officer, with a target effective date of July 31, 2023.

Perrigo to pitch over-the-counter birth control pill in May | Crain's Detroit Business - Vimarsana News

Perrigo to pitch over-the-counter birth control pill in May | Crain's Detroit Business

GRAND RAPIDS — Perrigo Co. plc is now scheduled to make a pitch in May to federal regulators who will decide whether to approve an over-the-counter daily birth control pill for the U.S. market. The company said Tuesday that the U.S. Food and Drug Administration rescheduled a joint meeting of…